Laboratory Assessment of von Willebrand Factor: Altered Interpretation of Laboratory Data, and Altered Diagnosis of von Willebrand's Disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 3, Issue 2, 1997, Pages 110-118

  Favaloro, Emmanuel J ^a   Mehrabani, Pirooz A ^a   Koutts, Jerry ^a  

^a Western Sydney Area Health Service   (Australia)

Author keywords

Diagnosis; Laboratory assessment; Normal ranges; Reference ranges; von Willebrand factor; von Willebrand's disease

Indexed keywords

EID: 84996247517     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969700300208     Document Type: Article

References (37)

1. Moroose R., Hoyer LW von Willebrand factor and platelet function. Annu Rev Med 1986; 37-157.
2. Giddings JC, Peake IR The investigation of factor VIII deficiency. In: Thompson JM, ed. Blood coagulation and haemostasis. New York: Churchill Livingstone, 1985:135.
3. Girma J-P., Meyer D., Verweij CL, et al. Structure-function relationship of human von Willebrand factor. Blood 1987; 70: 605.
4. Sadler JE Review: von Willebrand factor. J Biol Chem 1991: 266: 22777.
5. Sadler JE, Gralnck HR Commentary: A new classification for von Willebrand disease. Blood 1994; 84: 676.
6. Sadler JE A revised classification on von Willebrand disease. Thromb Haemost 1994; 71: 520.
7. Mannucci PM, Altieri D., Faioni E. Vasopressin analogues: their role in disorders of haemostasis. Ann NY Acad Sci 1987; 509: 71.
8. Rodeghiero F., Castamann G., Mannucci PM Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease Blood Rev 1991; 5: 155.
9. Mannucci PM, Cattaneo M. Desmopressin: a nontransfusional treatment of haemophilia and von Willebrand disease. Haemostasis 1992; 22: 276.
10. Badimon L., Badimon JJ, Chesebro JH, Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemost 1993; 70: 111.
11. Jansson J-H., Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351.
12. Nichols TC, Bellinger DA, Reddick RL, et al. Role of von Willebrand factor in arterial thrombosis: studies in normal and von Willebrand disease pigs. Circulation 1991; 83 (Suppl IV):IV-56.
13. Bloom AL von Willebrand factor: clinical features of inherited and acquired disorders. Mayo Clin Proc 1991; 66: 743.
14. Brinkhous KM, Reddick RL, Read MS, Nichols TC, Bellinger DA, Griggs TR von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura, and coronary artery thrombosis. Mayo Clin Proc 1991; 66: 733.
15. Gralnick HR von Willebrand factor, integrins, and platelets: their role in cancer. J Lab Clin Med 1992; 119: 444.
16. Stehouwer Cda, Nauta Jjp, Zeldenrust GC, Hackeng Whl, Donker Ajm, den Ottolander Gjh. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319.
17. Porta M., La Selva M., Molinatti PA von Willebrand factor and endothelial abnormalities in diabetic microangiopathy. Diabetes Care 1991; 14: 167.
18. Kazatchkine M., Sultan Y., Caen JP, Bariety J. Bleeding in renal failure: a possible cause. BMJ 1976;Sept:612.
19. Niesvizky R., Calandri C., Patel ND, Zhou S., Potter BJ, Rand JH von Willebrand factor binding to collagen in patients with end-stage renal disease. J Lab Clin Med 1994; 123: 137.
20. Ruggeri ZM, Ponticelli C., Mannucci PM Factor VIII and chronic renal failure. BMJ 1977;Apr:1085.
21. Herrmann RP, Marshall LR, Hurst PE Bleeding in renal failure: a possible cause. BMJ 1977;June:1601.
22. Remuzzi G., Livio M., Roncaglioni MC, Mecca G., Donati MB, de Gaetano G. Bleeding in renal failure: Is von Willebrand factor implicated? BMJ 1977;Aug:359.
23. Wegmuller E., Gruninger U., Furlan M., Beck EA, Hodler J., Reubi FC Factor VIII activity in chronic renal disease. Nephron 1981; 28: 157.
24. Castaman G., Rodeghiero F., Lattuada A., La-Greca G., Mannucci PM Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients. Am J Hematol 1993; 44: 266.
25. Caron C., Goudemand J., Marey A., Beague D., Ducroux G., Drouvin F. Are haemostatic and fibrinolytic parameters predictors of pre-eclampsia in pregnancy associated hypertension? Thromb Haemost 1991; 66: 410.
26. Hansen J-B., Wilsgard L., Olsen JO, Osterud B. Formation and persistence of procoagulant and fibrinolytic activities in circulation after strenuous physical exercise. Thromb Haemost 1990; 64: 385.
27. Jem C., Eriksson E., Tengbom L., Risberg B., Wadenvik H., Jem S. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 1989; 62: 767.
28. Brown JE, Bosak JO An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 1986; 43: 303.
29. Favaloro EJ, Grispo L., Exner T., Koutts J. Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between Type I and Type II, von Willebrand's disease. Blood Coag Fibrinolys 1991;2: 285.
30. Favaloro EJ Grispo L., Dinale A., Berndt M., Koutts J. von Willebrand's disease: laboratory investigation using an improved functional assay for von Willebrand factor. Pathology 1993;25: 152.
31. Favaloro EJ, Dean M., Grispo J., Exner T., Koutts J. von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy. Am J Hematol, 1994; 45: 205.
32. Favaloro EJ, Facey D., Grispo L. Laboratory assessment of von Willebrand factor: use of different assays can influence the diagnosis of von Willebrand's’ disease, dependent on dif fering sensitivity to sample preparation and differential recognition of high molecular weight vWF forms. Am J Clin Pathol 1995; 104: 264.
33. Healy Mjr, Ingram Gic. The “normal range” in tests of haemostasis. International Committee Communications. Thromb Haemost 1978; 39: 504.
34. Sadler JE, Matsushita T., Dong Z., Tuley EA, Westfield LA Molecular mechanism and classification of von Willebrand disease. Thromb Haemost 1995; 74: 161.
35. Blann AD, Mather H., Miller JP, McCollum CN Atherosclerosis risk factors: variations in healthy hospital workers and members of local communities asymptomatic for vascular disease. Implications for normal controls. Br J Biomed Sci 1995; 52: 31.
36. Ermens Aam, de Wild PJ, Vader HL, van der Graaf F. Four agglutination assays evaluated for measurement of von Willebrand factor (ristocetin cofactor activity). Clin Chem 1995; 41: 510.
37. Blomback M., Eneroth P., Andersson O., Anvret M. On laboratory problems in diagnosing mild von Willebrand's disease. Am J Hematol 1992;40: 117.